Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study (original) (raw)

Expert Opinion on Biological Therapy, 2011

Biologic therapy in the management of asthma

Current Opinion in Allergy and Clinical Immunology, 2016

Novel Biological Therapies for Severe Asthma Endotypes

Biomedicines, 2022

The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration

charles Irvin

Journal of Clinical Investigation, 1999

Molecular Targets for Biological Therapies of Severe Asthma

Frontiers in Immunology, 2020

Chronic inflammation and asthma

Jenna Macciochi

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010

The Prospects of an Active Vaccine Against Asthma Targeting IL-5

Antonia Fettelschoss

Frontiers in Microbiology, 2018

“Life-changing”: the experience of super-responders to biologics in severe asthma

Lucy Cartwright

BMC Pulmonary Medicine, 2022

Elucidating asthma phenotypes and endotypes: progress towards personalized medicine

John Oppenheimer

Annals of Allergy, Asthma & Immunology, 2016

Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma

Biomedicines, 2022

Minimal clinically important difference for asthma endpoints: an expert consensus report

Stefano Del Giacco

European Respiratory Review, 2020

Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma

Chris Corrigan

Thorax, 1994

Anti-IL5 therapy for asthma and beyond

Roma Sehmi

World Allergy Organization Journal, 2014

Infectious Diseases and Asthma. Preface

Shyam Mohapatra

Immunology and allergy clinics of North America, 2010

The New Gestalt: Asthma as a Chronic Inflammatory Disease

Steven Ackerman

Journal of Asthma, 1989

Future Research Directions in Asthma

Jack a. Elias

American Journal of Respiratory and Critical Care Medicine, 2004

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

Frontiers in Pharmacology, 2022

Eosinophilic inflammation in cough variant asthma

Akio Niimi

The European respiratory journal, 1998

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma

teresita aloè

BioMed Research International, 2018

Airway Inflammation and Remodeling in Asthma

Jack a. Elias

American Journal of Respiratory and Critical Care Medicine, 2001

Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study

Laura Elena Pineda Lancheros

International Journal of Molecular Sciences

Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study

medRxiv (Cold Spring Harbor Laboratory), 2024

Control measures in asthma: one size likely does not fit all

John Oppenheimer

Annals of Allergy, Asthma & Immunology, 2017

Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting

Journal of Clinical Medicine, 2023

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study

Stefano Del Giacco

Respiratory Research, 2023

How do biologicals and other novel therapies effect clinically used biomarkers in severe asthma?

John Upham

Clinical & Experimental Allergy, 2020

Asthma outcomes: Pulmonary physiology

charles Irvin

Journal of Allergy and Clinical Immunology, 2012

Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma

Bart Hilvering

Therapeutic Advances in Respiratory Disease, 2015

IL4R� Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression

Amer J Respir Crit Care Med, 2007

The new era of add-on asthma treatments: where do we stand?

Allergy, Asthma & Clinical Immunology, 2022

An ATS/ERS report: 100 key questions and needs in occupational asthma

Susan Tarlo

The European respiratory journal, 2006

IL-5 Levels in Nasosorption and Sputosorption Correlate with Sputum Eosinophilia in Allergic Asthma

Emílio Pizzichini

American journal of respiratory and critical care medicine, 2018

Emerging targets for novel therapy of asthma

Blanca Camoretti-mercado

Current Opinion in Pharmacology, 2013

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

Karl-Christian Bergmann

Journal of Asthma and Allergy

Interleukin-6 as a biomarker for asthma: hype or is there something else?

Charles Irvin

The European respiratory journal, 2016